Drugmakers Mallinckrodt and Endo Are in Talks to Merge
Mallinckrodt Pharmaceuticals and Endo Inc. are exploring a potential merger that could be valued at about $7 billion, people ...
Drugmakers Mallinckrodt and Endo get a bump from tariffs in $6.7 billion merger
Mallinckrodt and Endo , drugmakers which recently emerged from bankruptcy after a wave of U.S. opioid lawsuits, announced ...
Mallinckrodt to Take Over Endo in Deal Valued at $6.7 Billion
Ireland’s Mallinckrodt will buy U.S. drugmaker Endo in a cash-and-stock deal valued at $6.7 billion. The companies said ...
Mallinckrodt Pharma, Endo Reach Deal for $6.7 Billion Merger
Mallinckrodt Pharmaceuticals and Endo Inc. plan to merge and create a $6.7 billion company in a move that will cut costs and broaden access to patients and new treatments.
Mallinckrodt, Endo Merger To Create Pharma Entity Valued At $7 Billion
Mallinckrodt and Endo are merging in a $6.7 billion deal, with a pro forma NYSE listing and $900 million in financing.
The Business Journals8d
Endo to divest international pharma unit for $99M
The proposed sale comes nearly a year after Endo emerged from bankruptcy protection. Endo Inc. said Tuesday it has entered into an agreement to divest its international pharmaceuticals business to ...
Drugmakers Mallinckrodt, Endo in Talks to Merge, Source Says
Both Mallinckrodt and Endo have in the recent years faced lawsuits for their alleged role in the U.S. opioid epidemic. While ...
Reuters7d
Drugmakers Mallinckrodt, Endo in talks to merge, source says
March 12 (Reuters) - Mallinckrodt and Endo (NDOI.PK), opens new tab are exploring a potential merger that could be valued at about $7 billion, person familiar with the matter told Reuters on ...